The effectiveness of mindfulness-based stress reduction on the symptoms and quality of life in rosacea patients

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300070256

Enrollment

Unknown

Registered

2023-04-06

Start date

2023-03-31

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rosacea

Interventions

intervention group:Mindfulness-Based Stress Reduction practice

Waiting group:none

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with rosacea according to the Rosacea Treatment Guidelines (2017 Edition). Diagnosed by two senior dermatologists; The history was longer than 1 year; 2. Aged between 18 and 45; 3. The patient voluntarily participated in the clinical study and signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Age 45 years old; 2. Patients with other serious primary diseases of the heart, liver, kidney, blood, nervous system and skin; 3. Have taken pesticides, poisons or other substances that may cause damage to the central nervous system, and have a history of alcohol and drug abuse; 4. Self-administered antidepressant or other psychiatric drugs; 5. Pregnant and lactating patients.

Design outcomes

Primary

Measure	Time frame
Rosacea Area and Severity Index;	—

Secondary

Measure	Time frame
Dermatology Life Quality Index;Hospital Anxiety and Depression Scale;Facial visia image;Stigma questionnaire;Social Appearance Anxiety Questionnaire;Mindful Attention Awareness Scale;	—

Countries

China

Contacts

Public ContactJiang Xian

West China Hospital, Sichuan University

jiangxian@scu.edu.cn+86 189 8060 1693

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026